NASOPHARANGEAL CANCER
Clinical trials for NASOPHARANGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARANGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARANGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy trial aims to stop nasopharyngeal Cancer's return
Disease control Not yet recruitingThis large Phase 3 trial is testing if adding an oral chemotherapy drug (capecitabine) to a standard immunotherapy drug (adebrelimab) works better to control cancer after initial treatment. It's for patients with advanced nasopharyngeal cancer who still have signs of the Epstein-…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test Triple-Threat therapy for Tough-to-Treat head and neck cancer
Disease control Not yet recruitingThis study is testing whether adding a special low-dose radiation to a standard chemotherapy and immunotherapy combination can better control advanced nasopharyngeal cancer that has returned or spread. It will involve about 55 adults with this specific type of head and neck cance…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC